AAPL337.90+0.99 (+0.29%) ▲|ABBV266.37+9.46 (+3.68%) ▲|ABT109.22+4.73 (+4.53%) ▲|ACN165.68+11.62 (+7.54%) ▲|ADBE250.65+12.90 (+5.42%) ▲|AMAT471.63-45.26 (-8.76%) ▼|AMD447.58-47.37 (-9.57%) ▼|AMGN397.10+20.84 (+5.54%) ▲|AMT176.66+9.92 (+5.95%) ▲|AMZN229.83-1.56 (-0.67%) ▼|AVGO375.73-7.49 (-1.95%) ▼|AXP335.38-0.01 (0.00%) ▼|BA221.24+9.74 (+4.61%) ▲|BAC62.30+0.17 (+0.27%) ▲|BKNG195.24+8.45 (+4.52%) ▲|BLK1,081.76+19.62 (+1.85%) ▲|BMY64.82+2.26 (+3.61%) ▲|BNY155.84-1.94 (-1.23%) ▼|BRK-B510.65+13.47 (+2.71%) ▲|C131.91-1.19 (-0.89%) ▼|CAT827.31-45.97 (-5.26%) ▼|CL94.85+2.87 (+3.12%) ▲|CMCSA23.83+1.03 (+4.50%) ▲|COF208.47+1.42 (+0.69%) ▲|COP116.75+1.17 (+1.01%) ▲|COST984.80+33.22 (+3.49%) ▲|CRM181.37+7.77 (+4.47%) ▲|CSCO114.01-0.56 (-0.49%) ▼|CVS108.70+1.63 (+1.52%) ▲|CVX191.05+1.05 (+0.55%) ▲|DE636.17+11.15 (+1.78%) ▲|DHR203.77+7.27 (+3.70%) ▲|DIS98.87+2.22 (+2.30%) ▲|DUK132.33+3.50 (+2.72%) ▲|EMR150.88+1.58 (+1.06%) ▲|FDX309.64-1.15 (-0.37%) ▼|GD392.59+3.45 (+0.89%) ▲|GE364.02+2.41 (+0.67%) ▲|GEV918.83-77.74 (-7.80%) ▼|GILD135.29+4.77 (+3.65%) ▲|GM88.94+1.90 (+2.18%) ▲|GOOG327.45+0.88 (+0.27%) ▲|GOOGL327.60+1.04 (+0.32%) ▲|GS1,025.39-22.84 (-2.18%) ▼|HD346.74+10.65 (+3.17%) ▲|HON249.21+3.46 (+1.41%) ▲|IBM217.42+1.14 (+0.52%) ▲|INTC83.93-7.74 (-8.44%) ▼|INTU319.89+15.98 (+5.26%) ▲|ISRG370.77+13.94 (+3.91%) ▲|JNJ272.84+6.89 (+2.59%) ▲|JPM356.28+0.08 (+0.02%) ▲|KO89.84+5.77 (+6.86%) ▲|LIN520.82+13.80 (+2.72%) ▲|LLY1,226.52+28.99 (+2.42%) ▲|LMT587.06+7.06 (+1.22%) ▲|LOW219.39+7.84 (+3.71%) ▲|LRCX261.45-30.16 (-10.34%) ▼|MA561.16+9.45 (+1.71%) ▲|MCD278.58+7.91 (+2.92%) ▲|MDLZ63.31+2.64 (+4.35%) ▲|MDT88.80+4.58 (+5.43%) ▲|META593.99+0.12 (+0.02%) ▲|MMM182.68+4.45 (+2.50%) ▲|MO76.78+3.89 (+5.34%) ▲|MRK134.86+4.10 (+3.14%) ▲|MS209.60-4.96 (-2.31%) ▼|MSFT395.76+6.66 (+1.71%) ▲|MU801.74-98.47 (-10.94%) ▼|NEE90.81+1.98 (+2.23%) ▲|NFLX73.52+3.12 (+4.43%) ▲|NKE43.09+0.95 (+2.24%) ▲|NOW109.84+4.28 (+4.05%) ▲|NVDA193.84-2.67 (-1.36%) ▼|ORCL115.26-4.64 (-3.87%) ▼|PEP144.80+5.01 (+3.58%) ▲|PFE25.43+0.76 (+3.06%) ▲|PG152.57+3.94 (+2.65%) ▲|PLTR119.12-12.41 (-9.44%) ▼|PM206.49+10.83 (+5.54%) ▲|QCOM166.35-3.69 (-2.17%) ▼|RTX220.86+2.44 (+1.12%) ▲|SBUX105.09+1.44 (+1.39%) ▲|SCHW105.56+1.38 (+1.32%) ▲|SO98.55+2.07 (+2.15%) ▲|SPG236.89+5.22 (+2.25%) ▲|T25.14+0.72 (+2.93%) ▲|TMO580.32+20.79 (+3.72%) ▲|TMUS185.30+8.09 (+4.56%) ▲|TSLA302.13-7.09 (-2.29%) ▼|TXN277.03-2.39 (-0.85%) ▼|UBER69.25+1.07 (+1.57%) ▲|UNH418.36+0.72 (+0.17%) ▲|UNP301.69+2.39 (+0.80%) ▲|UPS107.62-5.33 (-4.72%) ▼|USB63.91+0.42 (+0.66%) ▲|V365.17+2.64 (+0.73%) ▲|VZ48.70+1.38 (+2.91%) ▲|WFC87.20-0.07 (-0.08%) ▼|WMT115.48+3.74 (+3.35%) ▲|XOM156.00+1.23 (+0.79%) ▲|AAPL337.90+0.99 (+0.29%) ▲|ABBV266.37+9.46 (+3.68%) ▲|ABT109.22+4.73 (+4.53%) ▲|ACN165.68+11.62 (+7.54%) ▲|ADBE250.65+12.90 (+5.42%) ▲|AMAT471.63-45.26 (-8.76%) ▼|AMD447.58-47.37 (-9.57%) ▼|AMGN397.10+20.84 (+5.54%) ▲|AMT176.66+9.92 (+5.95%) ▲|AMZN229.83-1.56 (-0.67%) ▼|AVGO375.73-7.49 (-1.95%) ▼|AXP335.38-0.01 (0.00%) ▼|BA221.24+9.74 (+4.61%) ▲|BAC62.30+0.17 (+0.27%) ▲|BKNG195.24+8.45 (+4.52%) ▲|BLK1,081.76+19.62 (+1.85%) ▲|BMY64.82+2.26 (+3.61%) ▲|BNY155.84-1.94 (-1.23%) ▼|BRK-B510.65+13.47 (+2.71%) ▲|C131.91-1.19 (-0.89%) ▼|CAT827.31-45.97 (-5.26%) ▼|CL94.85+2.87 (+3.12%) ▲|CMCSA23.83+1.03 (+4.50%) ▲|COF208.47+1.42 (+0.69%) ▲|COP116.75+1.17 (+1.01%) ▲|COST984.80+33.22 (+3.49%) ▲|CRM181.37+7.77 (+4.47%) ▲|CSCO114.01-0.56 (-0.49%) ▼|CVS108.70+1.63 (+1.52%) ▲|CVX191.05+1.05 (+0.55%) ▲|DE636.17+11.15 (+1.78%) ▲|DHR203.77+7.27 (+3.70%) ▲|DIS98.87+2.22 (+2.30%) ▲|DUK132.33+3.50 (+2.72%) ▲|EMR150.88+1.58 (+1.06%) ▲|FDX309.64-1.15 (-0.37%) ▼|GD392.59+3.45 (+0.89%) ▲|GE364.02+2.41 (+0.67%) ▲|GEV918.83-77.74 (-7.80%) ▼|GILD135.29+4.77 (+3.65%) ▲|GM88.94+1.90 (+2.18%) ▲|GOOG327.45+0.88 (+0.27%) ▲|GOOGL327.60+1.04 (+0.32%) ▲|GS1,025.39-22.84 (-2.18%) ▼|HD346.74+10.65 (+3.17%) ▲|HON249.21+3.46 (+1.41%) ▲|IBM217.42+1.14 (+0.52%) ▲|INTC83.93-7.74 (-8.44%) ▼|INTU319.89+15.98 (+5.26%) ▲|ISRG370.77+13.94 (+3.91%) ▲|JNJ272.84+6.89 (+2.59%) ▲|JPM356.28+0.08 (+0.02%) ▲|KO89.84+5.77 (+6.86%) ▲|LIN520.82+13.80 (+2.72%) ▲|LLY1,226.52+28.99 (+2.42%) ▲|LMT587.06+7.06 (+1.22%) ▲|LOW219.39+7.84 (+3.71%) ▲|LRCX261.45-30.16 (-10.34%) ▼|MA561.16+9.45 (+1.71%) ▲|MCD278.58+7.91 (+2.92%) ▲|MDLZ63.31+2.64 (+4.35%) ▲|MDT88.80+4.58 (+5.43%) ▲|META593.99+0.12 (+0.02%) ▲|MMM182.68+4.45 (+2.50%) ▲|MO76.78+3.89 (+5.34%) ▲|MRK134.86+4.10 (+3.14%) ▲|MS209.60-4.96 (-2.31%) ▼|MSFT395.76+6.66 (+1.71%) ▲|MU801.74-98.47 (-10.94%) ▼|NEE90.81+1.98 (+2.23%) ▲|NFLX73.52+3.12 (+4.43%) ▲|NKE43.09+0.95 (+2.24%) ▲|NOW109.84+4.28 (+4.05%) ▲|NVDA193.84-2.67 (-1.36%) ▼|ORCL115.26-4.64 (-3.87%) ▼|PEP144.80+5.01 (+3.58%) ▲|PFE25.43+0.76 (+3.06%) ▲|PG152.57+3.94 (+2.65%) ▲|PLTR119.12-12.41 (-9.44%) ▼|PM206.49+10.83 (+5.54%) ▲|QCOM166.35-3.69 (-2.17%) ▼|RTX220.86+2.44 (+1.12%) ▲|SBUX105.09+1.44 (+1.39%) ▲|SCHW105.56+1.38 (+1.32%) ▲|SO98.55+2.07 (+2.15%) ▲|SPG236.89+5.22 (+2.25%) ▲|T25.14+0.72 (+2.93%) ▲|TMO580.32+20.79 (+3.72%) ▲|TMUS185.30+8.09 (+4.56%) ▲|TSLA302.13-7.09 (-2.29%) ▼|TXN277.03-2.39 (-0.85%) ▼|UBER69.25+1.07 (+1.57%) ▲|UNH418.36+0.72 (+0.17%) ▲|UNP301.69+2.39 (+0.80%) ▲|UPS107.62-5.33 (-4.72%) ▼|USB63.91+0.42 (+0.66%) ▲|V365.17+2.64 (+0.73%) ▲|VZ48.70+1.38 (+2.91%) ▲|WFC87.20-0.07 (-0.08%) ▼|WMT115.48+3.74 (+3.35%) ▲|XOM156.00+1.23 (+0.79%) ▲|
26.3 C
New York
Tuesday, July 28, 2026

Tag: blood vessel

newssourceFORcompanyinformationcontent1releasesmarket

FDA Approves Labeled Strength Update of TWIRLA® (levonorgestrel/ethinyl estradiol) Birth Control Patch

FLORHAM PARK, N.J., June 19, 2026 (GLOBE NEWSWIRE) -- Exeltis USA, Inc. (Exeltis), a global pharmaceutical company specializing in women’s health, announced that the U.S. Food and Drug Administration (FDA) has approved an update to the labeled strength of TWIRLA® (levonorgestrel and ethinyl estradiol) transdermal system. The new labeled strength will begin to appear on the market in September or October of 2026.

Cumberland Pharmaceuticals and Vanderbilt Health Announce Potential New Therapy to Prevent Cancer Metastasis

Positive Results from Phase 2a Clinical TrialStudy met its primary endpoint demonstrating safety and tolerability of ifetroban in patients with high-risk solid tumorsTrial revealed promising...

GPCR-Targeting Therapies Market Poised for Strong Growth During the Forecast Period (2025-2034) Across 7MM Due to the Rising Cancer Diagnoses and Drug Pipeline Expansion...

The GPCR-targeting therapies market is expected to grow significantly in the coming years. This is due to the increasing number of patients who are...

GPCR-Targeting Therapies Market Poised for Strong Growth During the Forecast Period (2025-2034) Across 7MM Due to the Rising Cancer Diagnoses and Drug Pipeline Expansion...

The GPCR-targeting therapies market is expected to grow significantly in the coming years. This is due to the increasing number of patients who are...

Inozyme Pharma, Inc. Announces Postponement of 2025 Annual Meeting of Stockholders

BOSTON, June 20, 2025 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) today announced that it has postponed its 2025 Annual Meeting of Stockholders (the “Annual Meeting”), which was scheduled to be held on June 25, 2025, in light of the previously announced acquisition (the “Acquisition”) by BioMarin Pharmaceutical Inc. (“BioMarin”).

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsBlood vessel

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers